Chronic hepatitis C and fibrosis: evidences for possible estrogen benefits
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
The main injury caused by hepatitis C virus is the hepatic fibrosis, as a result of a chronic inflammatory process in the liver characterized by the deposit of components from the extracellular matrix. The fibrosis development leads to the modification of the hepatic architecture, of the hepatocellular function and to irregularities in the microcirculation. The tissue remodeling process observed in fibrosis has stellate cells, located at the space of Disse, as main acting agents. These cells, in response to a harmful stimulus, undergo phenotypic changes from non-proliferating cells to proliferating cells that express a- smooth-muscle actin (alpha-SMA), a process called as transdifferentiation. There are evidences that the oxidative stress is involved in the chronic liver disease and serves as bond between the injury and the hepatic fibrosis. A number of studies suggest that the estrogen, at physiological levels, presents an antifibrogenic action probably through an antioxidant effect, decreasing the levels of lipid peroxidation products in the liver and blood, thus inhibiting the myofibroblastic transformation of stellate cells and contributing for gender-associated differences in relation to the fibrosis development. The aim of this paper was to describe data from literature concerning the interaction between chronic hepatitis C and estrogens, pregnancy, use of oral contraceptives, menopause and hormone reposition therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the beneficial anti-fibrotic effect of ER activators in the hepatic tissue (e.g.17b-estradiol and estradiol) [200][201][202] may also explain sex differences in liver fibrosis and cirrhosis progression.[203][204][205][206]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [205]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Bataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472
Gressner, A. M., & Weiskirchen, R. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00292.x · Cited by 718 · cited 1×
“The accumulation of ECM proteins distorts the hepatic architecture and forms a fibrous scar with deposition of collagen, elastin and structural proteins [2,14].”
BackgroundA Revista da Sociedade Brasileira de Medicina Tropical
(1983) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86821983000100001 · Cited by 523
A comparison of fibrosis progression in chronic liver diseases
Poynard, T., Mathurin, P., Lai, C.-L., Guyader, D., Poupon, R., Tainturier, M.-H., Myers, R. P., Muntenau, M., Ratziu, V., Manns, M., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00413-0 · Cited by 474
Tsukada, S., Parsons, C. J., & Rippe, R. A. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.014 · Cited by 357
Wiese, M., Berr, F., Lafrenz, M., Porst, H., & Oesen, U. (2000) · Hepatology · doi:10.1053/jhep.2000.8169 · Cited by 349
Di Martino, V., Rufat, P., Boyer, N., Renard, P., Degos, F., Martinot-Peignoux, M., Matheron, S., Le Moing, V., Vachon, F., Degott, C., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.29201 · Cited by 335
Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats
Yasuda, M., Shimizu, I., Shiba, M., & Ito, S. (1999) · Hepatology · doi:10.1002/hep.510290307 · Cited by 283
Di Martino, V., Lebray, P., Myers, R. P., Pannier, E., Paradis, V., Charlotte, F., Moussalli, J., Thabut, D., Buffet, C., & Poynard, T. (2004) · Hepatology · doi:10.1002/hep.20463 · Cited by 280
Research works printed but not linked: 7
- Marcellin P., Asselah T., Boyer N. Fibrosis and disease progression in Hepatits C. Hepatology 2002;36:S47-56.
- Poynard T., Bedossa P., Opolon P., for the OBSVIRC, METAVIR, CLINIVIR and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic heptitis C. The Lancet 1997;349:825-32.
- Hezode C., Castera L., Chouteau P., et al. Stéatose et hepatite C. Gastroenterol Clin Biol 2003;27:1091-5.
- Kenny W.E. Clinical outcomes after hepatits C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 1999;340:1228-33.
- Grangé J.D., Abergel A., Amiot X., et al. Interactions entre l'hepatite virale chronique C et la grossesse Gastroenterol Clin Biol 1995;19:520-2.
- Codes L., Asselah T., Cazals-Hatem D., et al. Characteristics associated with progression of fibrosis in women with hepatits C: Evidence for the role of estrogen. Journal of Hepatology 2005;Suppl 2, vol 42:202(A556).
- Writing Group for The Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002;288:321-33.
Cited by
Gutierrez-Grobe, Y., Ponciano-Rodríguez, G., Ramos, M. H., Uribe, M., & Méndez-Sánchez, N. (2010) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31616-3 · Cited by 246
Nuclear Receptors as New Perspective for the Management of Liver Diseases
Trauner, M., & Halilbasic, E. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.044 · Cited by 118
Zhang, B., Zhang, C., Ji, L., Zhao, G., & Wu, Z. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13976 · Cited by 61
Sperm DNA damage in patients with chronic viral C hepatitis
Vignera, S. L., Condorelli, R. A., Vicari, E. S. D., D’Agata, R., & Calogero, A. E. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.08.011 · Cited by 48
Nuclear receptors in liver fibrosis
Königshofer, P., Brusilovskaya, K., Petrenko, O., Hofer, B. S., Schwabl, P., Trauner, M., & Reiberger, T. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166235 · Cited by 45
Metadata
- Authors
- Codes, L., Matos, L., & Paraná, R.
- Affiliations
- Universidade Federal da Bahia (BR)
- Venue
- Brazilian Journal of Infectious Diseases
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2007-06
- Volume
- 11
- Issue
- 3
- Pages
- 371-374
- ISSN
- 1413-8670 (ISSN-L)
- OpenAlex
- W2117054419
- Cited by
- 28
- References
- 28
- Citations by year
- 2026: 2 · 2024: 1 · 2022: 2 · 2021: 1 · 2019: 1 · 2018: 1 · 2017: 2 · 2015: 1 · 2014: 3 · 2013: 1 · 2012: 3
- FWCI
- 0.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- The Brazilian Journal of Infectious Diseases (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Americanae (AECID Library) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- chronic hepatitis C, liver fibrosis, estrogen, antifibrotic effect, oxidative stress, hepatic stellate cells, myofibroblast transdifferentiation, alpha-smooth muscle actin, lipid peroxidation, pregnancy, oral contraceptives, menopause, hormone replacement therapy
- MeSH terms
- Animals, Estrogens, Extracellular Matrix, Female, Humans, Liver Cirrhosis, Male, Pregnancy, Lipid Peroxidation, Oxidative Stress, Hepatitis C, Chronic, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic hepatitis C and fibrosis: evidences for possible estrogen benefits. https://app.cochat.ai/papers/10.1590/s1413-86702007000300014
- The paper
- Codes, L., Matos, L., & Paraná, R. (2007). Chronic hepatitis C and fibrosis: evidences for possible estrogen benefits. Brazilian Journal of Infectious Diseases. https://doi.org/10.1590/s1413-86702007000300014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.